194 related articles for article (PubMed ID: 38033098)
1. The association between bullous pemphigoid and cognitive outcomes in middle-aged and older adults: A systematic review and meta-analysis.
Zhou Q; Xiong Z; Yang D; Xiong C; Li X
PLoS One; 2023; 18(11):e0295135. PubMed ID: 38033098
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Association Between Medication Use and Bullous Pemphigoid: A Systematic Review and Meta-analysis.
Liu SD; Chen WT; Chi CC
JAMA Dermatol; 2020 Aug; 156(8):891-900. PubMed ID: 32584924
[TBL] [Abstract][Full Text] [Related]
4. Atopic dermatitis and cognitive dysfunction in middle-aged and older adults: A systematic review and meta-analysis.
Zhou Q; Yang D; Xiong C; Li X
PLoS One; 2023; 18(10):e0292987. PubMed ID: 37878635
[TBL] [Abstract][Full Text] [Related]
5. Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome.
Taylor-Rowan M; Edwards S; Noel-Storr AH; McCleery J; Myint PK; Soiza R; Stewart C; Loke YK; Quinn TJ
Cochrane Database Syst Rev; 2021 May; 5(5):CD013540. PubMed ID: 34097766
[TBL] [Abstract][Full Text] [Related]
6. Association of Age-Related Hearing Loss With Cognitive Function, Cognitive Impairment, and Dementia: A Systematic Review and Meta-analysis.
Loughrey DG; Kelly ME; Kelley GA; Brennan S; Lawlor BA
JAMA Otolaryngol Head Neck Surg; 2018 Feb; 144(2):115-126. PubMed ID: 29222544
[TBL] [Abstract][Full Text] [Related]
7. The association between cataract and incidence of cognitive impairment in older adults: A systematic review and meta-analysis.
Xiong Z; Li X; Yang D; Xiong C; Xu Q; Zhou Q
Behav Brain Res; 2023 Jul; 450():114455. PubMed ID: 37148915
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for mortality in patients with bullous pemphigoid: a meta-analysis.
Liu YD; Wang YH; Ye YC; Zhao WL; Li L
Arch Dermatol Res; 2017 Jul; 309(5):335-347. PubMed ID: 28317060
[TBL] [Abstract][Full Text] [Related]
9. Association between bullous pemphigoid and psychiatric disorders: A systematic review and meta-analysis.
Huang IH; Wu PC; Liu CW; Huang YC
J Dtsch Dermatol Ges; 2022 Oct; 20(10):1305-1312. PubMed ID: 36108333
[TBL] [Abstract][Full Text] [Related]
10. The global incidence of bullous pemphigoid: a systematic review and meta-analysis.
Persson MSM; Begum N; Grainge MJ; Harman KE; Grindlay D; Gran S
Br J Dermatol; 2022 Mar; 186(3):414-425. PubMed ID: 34480482
[TBL] [Abstract][Full Text] [Related]
11. Association of bullous pemphigoid with malignancy: A systematic review and meta-analysis.
Atzmony L; Mimouni I; Reiter O; Leshem YA; Taha O; Gdalevich M; Hodak E; Mimouni D
J Am Acad Dermatol; 2017 Oct; 77(4):691-699. PubMed ID: 28645646
[TBL] [Abstract][Full Text] [Related]
12. The association between neurological diseases, malignancies and cardiovascular comorbidities among patients with bullous pemphigoid: Case-control study in a specialized Polish center.
Kalińska-Bienias A; Kowalczyk E; Jagielski P; Bienias P; Kowalewski C; Woźniak K
Adv Clin Exp Med; 2019 May; 28(5):637-642. PubMed ID: 30784240
[TBL] [Abstract][Full Text] [Related]
13. Bullous pemphigoid and diabetes mellitus: a systematic review and meta-analysis.
Jiirasutat N; Pongchareon P; Weschawalit S
Int J Dermatol; 2024 May; 63(5):572-579. PubMed ID: 38217028
[TBL] [Abstract][Full Text] [Related]
14. Risk of venous thromboembolism in patients with bullous pemphigoid: A systematic review and meta-analysis.
Ungprasert P; Wijarnpreecha K; Thongprayoon C
Indian J Dermatol Venereol Leprol; 2018; 84(1):22-26. PubMed ID: 29185440
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of diabetes mellitus in bullous pemphigoid patients in the absence of dipeptidyl peptidase-4 inhibitors: a systematic review and meta-analysis.
Guo W; Rathi S; Marquez J; Smith H; Kuruvilla A; Tonnesen MG; Salvemini JN
Arch Dermatol Res; 2023 Oct; 315(8):2207-2213. PubMed ID: 36867222
[TBL] [Abstract][Full Text] [Related]
16. Peripheral high levels of CRP predict progression from normal cognition to dementia: A systematic review and meta-analysis.
Long S; Chen Y; Meng Y; Yang Z; Wei M; Li T; Ni J; Shi J; Tian J
J Clin Neurosci; 2023 Jan; 107():54-63. PubMed ID: 36502782
[TBL] [Abstract][Full Text] [Related]
17. Association between bullous pemphigoid and psoriasis: Systematic review and meta-analysis of case-control studies.
Phan K; Goyal S; Murrell DF
Australas J Dermatol; 2019 Feb; 60(1):23-28. PubMed ID: 30141189
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Risk of Bullous Pemphigoid With Initiation of Dipeptidyl Peptidase-4 Inhibitor vs Second-generation Sulfonylurea.
Lee H; Chung HJ; Pawar A; Patorno E; Kim DH
JAMA Dermatol; 2020 Oct; 156(10):1107-1114. PubMed ID: 32697283
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
